Identification of Antigenic Targets.

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• The search for ideal cancer target antigens (Ags) with high tumor specificity and essential roles in cancer survival has yielded limited success.
• Existing cell surface Ags often fail to meet the stringent criteria for effective cancer targeting.

Purpose of the Study:

• To explore the potential of intracellular targets, presented as peptide-human leukocyte antigen (pHLA) complexes, as ideal targets for cancer therapy.
• To evaluate pHLA-target Ags as a promising strategy for solid tumor treatment.

Main Methods:

• Analysis of recent clinical trials involving immune checkpoint inhibitors (ICIs).
• Investigation of cluster of differentiation (CD)8+ T cell responses mediated by T cell receptors (TCRs) recognizing pHLA molecules on tumor cells.

Main Results:

• Immune checkpoint inhibitors demonstrate that CD8+ T cells recognizing intracellular targets via pHLA complexes can induce significant and durable antitumor responses in solid tumors.
• This indicates the therapeutic potential of targeting pHLA molecules.

Conclusions:

• Peptide-human leukocyte antigen (pHLA)-target antigens represent a potentially ideal class of targets for solid tumors.
• These targets may enable the development of highly potent oncology compounds for improved cancer treatment.